cardio-respiratory instability Prematurity
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: * Admitted to a participating NICU * Being routinely monitored using adhesive electrodes for cardiorespiratory monitoring * Written parental informed consent * Of a post-menstrual age (PMA) cohort that is not already fully represented in the study (to include representative numbers, inclusion is performed based on three cohorts, PMA 37 weeks)
Exclusion criteria
Exclusion criteria: * Chest skin lesions preventing placement of electrode belt, since the intended use of the belt is for intact skin. * Congenital anomalies preventing placement of electrode belt * (Effects of) surgery preventing or hindering belt placement, such as a laparotomy or stoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoints are a) equivalence of heart rate monitoring (as measured by i) second-to-second correlation and level of agreement, and ii) bradycardia and tachycardia sensitivity and positive predictive value (PPV)) and b) safety (as measured by data loss and pre-defined relevant adverse events and adverse device effects). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are equivalence of respiratory monitoring, and the visual interpretability of waveforms (ECG and respiration waveforms) as rated by independent, blinded experts. | — |
Countries
Netherlands